This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Xenon Pharmaceuticals, Inc.
Drug Names(s): XEN801
Description: XEN801 is a topically administered, selective, small molecule inhibitor of stearyl Co-A desaturase (SCD1), an enzyme involved in lipid synthesis that is expressed in sebaceous glands in the skin.
Pink Sheet Weekly Trademark Review June 5, 2012
Additional information available to subscribers only: